Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 1262, pseudogene (abbreviated as RNU6-1262P) is a human gene classified as a pseudogene. It is not a protein-coding gene and does not encode a functional product; rather, it is a remnant of a once-functional gene that now lacks biological activity. RNU6-1262P is a genomic element classified as a processed small nuclear RNA pseudogene located on chromosome 16. Pseudogenes such as RNU6-1262P are derived from functional genes (in this case, U6 small nuclear RNA genes) but have lost their ability to encode functional RNA through evolutionary events, such as duplication and retrotransposition. U6 snRNA pseudogenes have been used as markers of retrotransposition dynamics and genome evolution. Unlike the functional U6 snRNA, which plays a key role in the spliceosomal excision of introns from pre-mRNA, RNU6-1262P does not participate in any cellular biological process or have any known disease associations. It is not considered a therapeutic or pharmacological target in any context. Its only significance is as a genomic marker of retrotransposition history within the human genome.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1262, pseudogene (RNU6-1262P).